Andrea Ribeiro de Souza, Vincenzo La Mura, Annalisa Berzigotti, Juan Carlos García‐Pagán, Juan G. Abraldes, Jaime Bosch – 4 September 2015 – Nonselective beta‐blockers (NSBB) are widely used because they have been proved effective in the prophylaxis of acute variceal bleeding (AVB). However, a significant proportion of patients still experience AVB while on treatment with NSBB, and its impact on prognosis of AVB is unknown.

Lesley De Pietri, Marcello Bianchini, Roberto Montalti, Nicola De Maria, Tommaso Di Maira, Bruno Begliomini, Giorgio Enrico Gerunda, Fabrizio di Benedetto, Guadalupe Garcia‐Tsao, Erica Villa – 4 September 2015 – Bleeding is a feared complication of invasive procedures in patients with cirrhosis and significant coagulopathy (as defined by routine coagulation tests) and is used to justify preprocedure use of fresh frozen plasma (FFP) and/or platelets (PLT).

Kenneth E. Sherman, Juergen Rockstroh, David Thomas – 4 September 2015 – Human immunodeficiency viral (HIV) infection affects approximately 1.2 million persons in the United States and 35 million worldwide. Progression to advanced liver disease remains a leading cause of death among HIV‐infected persons in the United States and elsewhere. Though mortality from HIV complications has been dramatically reduced wherever effective combination antiretroviral therapy is used, there has been little impact on liver‐related mortality.

Barbara Testoni, Fabien Zoulim – 4 September 2015

Andrea Ribeiro de Souza, Vincenzo La Mura, Annalisa Berzigotti, Juan Carlos García‐Pagán, Juan G. Abraldes, Jaime Bosch – 4 September 2015 – Nonselective beta‐blockers (NSBB) are widely used because they have been proved effective in the prophylaxis of acute variceal bleeding (AVB). However, a significant proportion of patients still experience AVB while on treatment with NSBB, and its impact on prognosis of AVB is unknown.

Barbara Testoni, Fabien Zoulim – 4 September 2015

Liu‐Xiao Yang, Qiang Gao, Jie‐Yi Shi, Zhi‐Chao Wang, Yong Zhang, Ping‐Ting Gao, Xiao‐Ying Wang, Ying‐Hong Shi, Ai‐Wu Ke, Guo‐Ming Shi, Jia‐Bin Cai, Wei‐Ren Liu, Meng Duan, Ying‐Jun Zhao, Yuan Ji, Dong‐Mei Gao, Kai Zhu, Jian Zhou, Shuang‐Jian Qiu, Ya Cao, Qi‐Qun Tang, Jia Fan – 4 September 2015 – The molecular pathogenesis of intrahepatic cholangiocarcinoma (iCCA) is poorly understood, and its incidence continues to increase worldwide.

Kai Markus Schneider, Veerle Bieghs, Oliver Pabst, Christian Trautwein – 3 September 2015

Valeria R. Mas – 3 September 2015

Apurva A. Modi, Hector Nazario, James F. Trotter, Manjushree Gautam, Jeffrey Weinstein, Parvez Mantry, Maisha Barnes, Adil Habib, Jean McAfee, Olga Teachenor, Lauren Tujague, Stevan Gonzalez – 3 September 2015 – Combination antiviral therapy involving sofosbuvir (SOF) and simeprevir (SIM) is a treatment option in patients with genotype 1 chronic hepatitis C; however, the safety of this regimen in patients with decompensated cirrhosis is not established.